(1)
Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Mongolian Patients With Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the SIRveNIB Study. Cent Asian J Med Sci 2019, 5 (3), 188-196. https://doi.org/10.24079/cajms.2019.09.005.